1. Indolent T-cell lymphoproliferative disorder of the stomach successfully treated by radiotherapy
- Author
-
Shin Arai, Tomoya Maeda, Naoki Takahashi, Yu Akuzawa, Nobutaka Kawai, Daisuke Okamura, Mika Kohri, Eiichi Arai, Tsuyoshi Saeki, Akira Matsuda, Maho Ishikawa, Kunihiro Tsukasaki, and Norio Asou
- Subjects
involved field radiotherapy ,0301 basic medicine ,medicine.medical_specialty ,T-Lymphocytes ,medicine.medical_treatment ,Case Report ,Asymptomatic ,03 medical and health sciences ,0302 clinical medicine ,Stomach Neoplasms ,ITLPDGL ,Biopsy ,medicine ,Humans ,Aged ,Chemotherapy ,Gastrointestinal tract ,treatment ,medicine.diagnostic_test ,business.industry ,gastric cancer ,Stomach ,General Medicine ,Lymphoproliferative Disorders ,Endoscopy ,Radiation therapy ,Treatment Outcome ,030104 developmental biology ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Female ,Radiology ,medicine.symptom ,lymphoproliferative disorder ,business ,Watchful waiting - Abstract
Successful treatment of indolent T-cell lymphoproliferative disorder of the gastrointestinal tract (ITLPDGI) by chemotherapy is rare and watchful waiting is often performed for asymptomatic patients. We report a case of ITLPDGI successfully treated by involved field radiotherapy (IFRT). The patient presented with slow ITLPDGI localised to the stomach with mild symptoms. IFRT (30 Gy/20f) was administered, after which endoscopy revealed resolution of lesions and blood vessel appearance, and absence of proliferating abnormal lymphocytes was confirmed by biopsy. The patient remains lymphoma-free 1 year post-treatment. Although long-term follow-up and additional cases are essential for the evaluation of IFRT as a treatment option for localised ITLPDGL, complete remission after relatively low-dose IFRT is promising, particularly as this has been rarely achieved by chemotherapy.
- Published
- 2020
- Full Text
- View/download PDF